BUPHENYL ® is a registered trademark of Ucyclyd Pharma, Inc.

CONTACT: Shari Annes, Investor Relations         Cell: 650 888 0902         sannes@annesassociates.com

If you liked this article you might like

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

Stock Markets Soar on Trifecta of Good News

Energy Sector Leads Stock Markets Higher as Rally Rolls On

Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion